0001104659-21-083610.txt : 20210621
0001104659-21-083610.hdr.sgml : 20210621
20210621172713
ACCESSION NUMBER: 0001104659-21-083610
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210617
FILED AS OF DATE: 20210621
DATE AS OF CHANGE: 20210621
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bonello Michael J.
CENTRAL INDEX KEY: 0001738327
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36732
FILM NUMBER: 211032053
MAIL ADDRESS:
STREET 1: 4130 PARKLAKE AVENUE
STREET 2: SUITE 400
CITY: RALEIGH
STATE: NY
ZIP: 27612
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PRA Health Sciences, Inc.
CENTRAL INDEX KEY: 0001613859
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 463640387
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4130 PARKLAKE AVENUE
STREET 2: SUITE 400
CITY: RALEIGH
STATE: NC
ZIP: 27612
BUSINESS PHONE: 9197868200
MAIL ADDRESS:
STREET 1: 4130 PARKLAKE AVENUE
STREET 2: SUITE 400
CITY: RALEIGH
STATE: NC
ZIP: 27612
4
1
tm2120078-5_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-06-17
0
0001613859
PRA Health Sciences, Inc.
PRAH
0001738327
Bonello Michael J.
C/O PRA HEALTH SCIENCES, INC.
4130 PARKLAKE AVENUE, SUITE 400
RALEIGH
NC
27612
0
1
0
0
EVP & CFO
Common Stock
2021-06-17
4
M
0
35661
81.61
A
47525
D
Common Stock
2021-06-17
4
M
0
8334
95.94
A
55859
D
Common Stock
2021-06-17
4
M
0
8556
103.30
A
64415
D
Common Stock
2021-06-17
4
S
0
200
166.70
D
64215
D
Common Stock
2021-06-17
4
S
0
24389
168.17
D
39826
D
Common Stock
2021-06-17
4
S
0
22587
169.05
D
17239
D
Common Stock
2021-06-17
4
S
0
5375
169.67
D
11864
D
Stock Options (Right to Buy)
81.61
2021-06-17
4
M
0
35661
0
D
2028-04-26
Common Stock
35661
20000
D
Stock Options (Right to Buy)
95.94
2021-06-17
4
M
0
8334
0
D
2029-08-13
Common Stock
8334
16666
D
Stock Options (Right to Buy)
103.30
2021-06-17
4
M
0
8556
0
D
2030-06-01
Common Stock
8556
17114
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $166.55 to $166.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2), (3), (4) and (5) of this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $167.57 to $168.56, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $168.57 to $169.55, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $169.57 to $169.83, inclusive.
12,877 options vested on April 26, 2019 and 4,339 options vested on April 26, 2020 upon satisfaction of certain performance criteria.
The option vests in three equal annual installments of 8,334 beginning on August 13, 2020.
The option vests in three equal annual installments of 8,556 beginning on June 1, 2021.
By: /s/ Christopher L. Gaenzle, by power of attorney
2021-06-21